Polomar Health Services, Inc. (PMHS): auditor change — Polomar Health restates Q3 2024 financials; acquisition reclassified as recapitalization

Polomar Health Services, Inc.

SEC comment letter prompted reclassification of Sep 30, 2024 acquisition from reverse merger to recapitalization.
Restatement will materially impact previously reported balance sheets and statements of stockholders' deficit.
Net loss, stockholders' equity, EPS, cash flow, and non-GAAP measures are unaffected by the reclassification.
Company plans to file an amended Form 10-Q for the three and nine months ended Sep 30, 2024 as soon as practicable.

item 4.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Polomar Health Services, Inc. reported that prior financial statements should not be relied upon.

Action: non reliance
Auditor: GreenGrowth CPA LLP

Exact text from the filing

the Company concluded that the accounting treatment relating to the Company’s September 30, 2024 acquisition of Polomar Specialty Pharmacy, LLC, a Florida limited liability company (“Polomar”), whereby, among other things, the Company acquired 100% of Polomar in exchange for the issuance of shares of the Company’s common stock, and Polomar became the wholly-owned subsidiary of the Company (the “Acquisition”), as previously disclosed in the Original Form 10-Q, should no longer be relied upon.

View on SEC.gov

56 auditor changes filed in the last 30 days. Browse all auditor changes →

Polomar Health Services, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-009233

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.